Biomaterials‐Based Cell Therapy for Myocardial Tissue Regeneration
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202202699 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Lei Mu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, 710049, Ch…. Hauptthemen laut MEDLINE: Biocompatible Materials, Heart Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 187 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shaanxi Province, State Key Laboratory for Mechanical Behavior of Materials.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) have been the leading cause of death worldwide during the past several decades. Cell loss is the main problem that results in cardiac dysfunction and further mortality. Cell therapy aiming to replenish the lost cells is proposed to treat CVDs especially ischemic heart diseases which lead to a big portion of cell loss. Due to the direct injection's low cell retention and survival ratio, cell therapy using biomaterials as cell carriers has attracted more and more attention because of their promotion of cell delivery and maintenance at the aiming sites. In this review, the three main factors involved in cell therapy for myocardial tissue regeneration: cell sources (somatic cells, stem cells, and engineered cells), chemical components of cell carriers (natural materials, synthetic materials, and electroactive materials), and categories of cell delivery materials (patches, microspheres, injectable hydrogels, nanofiber and microneedles, etc.) are systematically summarized. An introduction of the methods including magnetic resonance/radionuclide/photoacoustic and fluorescence imaging for tracking the behavior of transplanted cells in vivo is also included. Current challenges of biomaterials‐based cell therapy and their future directions are provided to give both beginners and professionals a clear view of the development and future trends in this area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, 710049, China.
- State Key Laboratory for Mechanical Behavior of Materials, and Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China.
ORCID-Profile: Baolin Guo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shaanxi Province
- State Key Laboratory for Mechanical Behavior of Materials
- Fundamental Research Funds for the Central Universities
- China Postdoctoral Science Foundation
Zitieren
APA
Mu, L., Dong, R., & Guo, B. (2023). Biomaterials‐Based Cell Therapy for Myocardial Tissue Regeneration. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202202699
Vancouver
Mu L, Dong R, Guo B. Biomaterials‐Based Cell Therapy for Myocardial Tissue Regeneration. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202202699
BibTeX
@article{Mu2023,
author = {Mu, Lei and Dong, Ruonan and Guo, Baolin},
title = {Biomaterials‐Based Cell Therapy for Myocardial Tissue Regeneration},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202202699}
}
EUVIMED